Leidos Holdings, Inc. business relationships

Companies named in Leidos Holdings, Inc.’s 10-K filed 2026-02-17, and public companies whose annual reports name Leidos Holdings, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 6.6 / 10
AI naming: 100 / 100
Agent readiness: 10 / 100
AI adoption: 8 / 100

Layers: Space Defense

Named in Leidos Holdings, Inc.’s annual report 1

Centerra Group, LLCPartner4.7
“...est in Hanford Mission Integration Solutions, LLC ("HMIS"), the legal entity for the follow-on contract to Mission Support Alliance, LLC's ("MSA") contract and a joint venture with Centerra Group, LLC and Parsons Government Services, Inc. In fiscal 2025, we dissolved our controlling interest in MSA.” SEC filing

Companies whose annual reports name Leidos Holdings, Inc. 7

PARSONS CORP (PSN)names it as supplier6.1
“Our peer group in Federal Solutions are U.S. federal systems integrators and service providers such as Booz Allen Hamilton, CACI International Inc, Leidos Holdings, Inc., and Science Applications International Corporation.” SEC filing
Nauticus Robotics, Inc. (KITT)names it as partner5.5
“On January 30, 2025, Nauticus announced a strategic alliance with Leidos, its strategic partner for defense related pursuits.” SEC filing
KULR Technology Group, Inc. (KULR)names it as partner5.4
“The Company has partnered with Lockheed Martin, Leidos and other prime contractors to develop and supply mission-critical technologies for hypersonic vehicles, high-power magnetic wave, and other defense systems.” SEC filing
LSB INDUSTRIES, INC. (LXU)names it as customer5.4
“We are pursuing the recovery of any damage or loss caused by Global's work performed at our El Dorado Facility through their contract with the Leidos Entities.” SEC filing
MOBIX LABS, INC (MOBX)names it as customer5.2
“the year ended September 30, 2025, sales to Leidos Holdings, Inc. accounted for approximately 50% of our net revenues.” SEC filing
BridgeBio Oncology Therapeutics, Inc. (BBOT)names it as licensor4.6
“On August 5, 2022, BBOT entered into a patent license agreement (the " Leidos PLA II ") with Leidos, pursuant to which BBOT received a worldwide, exclusive, royalty-bearing, sublicensable (through multiple tiers) license under patent rights relating to the KRAS G12C inhibitor compounds to (i) make a...” SEC filing
BridgeBio Oncology Therapeutics, Inc. (BBOT)names it as partner4.6
“The licensed patent rights result from an ongoing research collaboration between BBOT and Leidos, and BBOT may opt to negotiate an exclusive license to any additional inventions resulting” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.